SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

NGM Biopharmaceuticals Q1 EPS $(0.280) Up From $(1.210) YoY, Sales $24.364M Down From $25.552M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.280) per share. This is a 76.86 percent increase over losses of $(1.210) per share from the same period last year. The company reported $24.364

Benzinga · 05/13/2020 20:08

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.280) per share. This is a 76.86 percent increase over losses of $(1.210) per share from the same period last year. The company reported $24.364 million in sales this quarter. This is a 4.65 percent decrease over sales of $25.552 million the same period last year.